ABC News eliminating 538 amid layoffs
The layoffs are expected to impact 200 employees which represents under 6 percent of the staff at the company and Disney Entertainment Networks unit. Fifteen employees at 538 will be let go.
The Wall Street Journal first reported the reductions.
The move is a part of broader consolidation efforts that include changes to ABC's on air programming, sources told The Hill.
The network's '20/20' and 'Nightline' shows are set to be merged into one broadcast segment while the 'Good Morning America' production team will be shaved down into management overseen by one person, Simone Swink.
Seni Tienabeso was named to the new role of VP, ABC News Live and some specialized units
ABC cut approximately 75 jobs last fall under the leadership of Almin Karamehmedovic who was named president of the network in August of last year.
Disney Entertainment Networks will also face workforce reductions amid low ratings, the sources said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
2 days ago
- The Hill
Billy Long to depart as IRS commissioner
Former Rep. Billy Long (R-Mo.) is being replaced as commissioner of the IRS less than two months after he was confirmed by the Senate, a White House official confirmed to The Hill. Treasury Secretary Scott Bessent will lead the agency on an acting basis, the official confirmed. Long was confirmed in June in a 53-44 party-line vote, with all Democrats voting in opposition to his confirmation. Long is a strong ally of President Trump, but he drew criticism from Democrats for his lack of experience and background with tax policy. The New York Times first reported on Long's exit. Trump has overseen a sweeping purge of the staff at the IRS, as he and other Republicans had regularly criticized spending in legislation during the Biden administration that allowed for the hiring of thousands of additional workers to crackdown on tax cheats to collect more revenue for the government. The National Taxpayer Advocate's mid-year report found that the IRS's taxpayer services division was expected to lose roughly 22 percent of its workforce. Long served in Congress from 2011 to 2023, and at one sponsored legislation to abolish the IRS. He previously worked as an auctioneer and real estate broker.
The Hill
2 days ago
- The Hill
Scaramucci: 50-basis-point cut from Fed possible next month
President Trump's former communications director Anthony Scaramucci on Friday said the Federal Reserve could reduce the interest rate following the onslaught of tariffs. 'I think the economy is weakening and you may even get a 50-basis-point cut from the Federal Reserve in September,' Scaramucci told MSNBC. Trump has been urging Federal Reserve Chair Jerome Powell to lower rates and has threatened to nix him over inaction. However, ultimately the leader decided against the move in an effort not to rattle the markets. Economists who previously predicted a recession due to fluctuating trade policy have now seen gains and some including 'Shark Tank' investor Kevin O'Leary have lauded Trump for negotiating tariff rates expected to generate billions. 'The economy is doing better than people had expected, but I think that's a lot of front-loading, Joe. And just to use that Wall Street term, people are looking at those tariffs, they front-loaded a lot of activity before those tariffs went into effect, the result of which you've had decent numbers now, but you are seeing some deceleration,' Scaramucci said earlier on the segment. 'And of course, a lot of American companies, like General Motors, who took an $800 million charge to absorb some of those tariffs, are not going to be able to do that permanently unless there's more flexibility on the tariffs. So it's a mixed bag, in quick summary,' he added, evaluating the financial impact of Trump's first six months in office. White House trade adviser Peter Navarro said the Fed may have cut interest rates earlier if recent job reports were more accurately presented. The Bureau of Labor Statistics reported that 73,000 jobs were created last month after correcting May's report to reflect the creation of 19,000 jobs compared to an initial report of 144,000. The Bureau also corrected the number from June to 14,000 job adds after an initial report of 147,000. 'It's is that if we had gotten that data when, when we should have got that data, the Federal Reserve yesterday would have lowered interest rates by at least 50 basis points. So you think so kind of incompetence or political no question about it,' Navarro said during an appearance on NewsNations' 'The Hill with Blake Burman. 'I mean, look, you had three months that were two months that revised significantly downward, one which was lower than expectations. I mean, the Fed, that's a completely different picture. I mean, there was a strong case for a 50 day there's an overwhelming case for a 50 basis point cut,' he added.
The Hill
3 days ago
- The Hill
Two more cases challenging Medicare negotiation rejected in federal courts
Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare Drug Price Negotiation Program, delivering two more blows to the pharmaceutical industry this week after an appeals court upheld the dismissal of a similar case. In Connecticut, the U.S. Second Circuit Court of Appeals upheld a decision granted by U.S. District Judge Michael P. Shea last year against pharmaceutical company Boehringer Ingelheim. The company's diabetes medication Jardiance was among the first 10 drugs chosen for Medicare negotiations and two more of its products were chosen for the following round of negotiations. In his 2024 ruling, Shea found that Boehringer Ingelheim could not demonstrate irreparable harm as a result of Medicare negotiations and also agreed with the federal government that the program did not violate laws such as the Medicare Act or the Administrative Procedures Act. Boehringer Ingelheim had also argued Medicare negotiations violated its First and Fifth Amendment rights. In its ruling on Thursday, the Second District Court of Appeals concurred with Shea's ruling, finding that the company's claims of unconstitutionality were not proven in their argument. 'Participation in the Negotiation Program is voluntary and thus does not entail an unlawful deprivation of rights,' the judgment stated. 'The program does not impose unconstitutional conditions on Boehringer's ability to participate in Medicare and Medicaid because the program is designed to promote the legitimate government purpose of controlling Medicare spending and does not regulate the company's conduct in the private market.' The Hill has reached out to Boehringer Ingelheim for comment. In Texas, Senior U.S. District Judge David Alan Ezra dismissed the lawsuit brought forward by the trade group PhRMA with prejudice, closing the case. As in Connecticut and other cases challenging Medicare negotiations, Ezra noted that drugmaker participation in Medicare is entirely voluntary. Ezra stated that because of the voluntary participation, drugmakers do not have a protected interest to sell drugs to Medicare at their preferred 'fair market value.' He similarly found that the plaintiffs had failed to demonstrate that they will suffer irreparable harm due to negotiating drug prices and was unconvinced of claims that the program violated the plaintiffs' Fifth and Eighth Amendment rights. 'In sum, Plaintiffs cannot demonstrate that the Program deprives them of a protected interest and therefore their Due Process Clause claim fails as a matter of law,' wrote Ezra, granting the federal government's request for summary judgment. The Hill has requested comment from PhRMA. These decisions come just one day after a federal judge upheld a ruling to dismiss a similar challenge to Medicare negotiations brought forward by the U.S. Chamber of Commerce. The courts found that several of the plaintiffs attached to the case lacked standing to sue. Merith Basey, executive director of the advocacy group Patients For Affordable Drugs, lauded the rulings in a statement Thursday. 'Once again, a drug company brought its high-priced lawyers to lay out its arguments against Medicare negotiation, and once again they have lost. This ruling against Boehringer Ingelheim marks the fifth consecutive legal victory for patients who have long awaited relief from Big Pharma's monopoly control over drug prices,' said Basey. 'It's truly US v Big Pharma. Patients For Affordable Drugs stands firm in our commitment to defending the hard-won Medicare negotiation program against Big Pharma's relentless attempts to undermine it at the expense of patients,' she added.
